McCormick beats Q1 estimates but shares slide ~9% on Unilever Foods merger

Transcript intelligence

What changed

McCormick reported FY2026 Q1 EPS of $0.66 versus $0.594 estimated (+11.1%) and revenue of $1.87 billion versus $1.79 billion estimated (+4.9%). Alongside the results, management unveiled a Reverse Morris Trust combination with Unilever Foods. The market reacted negatively on the session despite the beats: an abnormal move of roughly -9.0% versus a positive benchmark move, on about 3.1x normal volume.

Guidance delta

Management maintained guidance sentiment. The deal outlook targets 3-5% organic sales growth and margin expansion to 23-25% by year three post-synergies, with pro-forma 2025 net sales of ~$20B at ~21% operating margins. Dividend policy stays unchanged, and net leverage is expected to decline from ~4x at close to ~3x within two years.

Key takeaways

• FY2026 Q1 EPS of $0.66 beat consensus by ~11%; revenue of $1.87B beat by ~5%.
• Management announced a Reverse Morris Trust combination with Unilever Foods creating a global flavor leader; Unilever shareholders receive 65% of combined equity, McCormick shareholders 35%.
• Targeted annual run-rate cost synergies of $600M, with $100M reinvested in brand marketing and innovation.
• Pro-forma 2025 net sales of ~$20B with operating margins of ~21%, seen expanding to 23-25% after synergies.
• Dividend policy unchanged; net leverage expected to fall from ~4x at close to ~3x within two years.
• The stock fell ~9% on the announcement session on ~3x normal volume despite the earnings beat.

Management priorities

• Deploy $100M of incremental marketing and innovation spend.
• Accelerate geographic expansion of high-growth brands such as Cholula and Frank's.
• Scale the dual-engine Food Service platform globally, including front-of-house and back-of-house cross-selling.
• Launch new flavor innovations leveraging combined R&D capabilities.
• Maintain and potentially increase the dividend while deleveraging toward ~3x net leverage.